Delivery Order SPE2DB24D6044-SPE2DB25FLJJV
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gentamicin 800 mg/20 mL vials totaling $1,791.07. This is a firm fixed-price delivery order under a non-competitive award with an ultimate completion date of September 18, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued as a child contract...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Gentamicin 800 mg/20 ml vials with a firm fixed price ceiling value of $2,425.09. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on June 26, 2025, for the supply of Gentamicin 800 mg/20 mL vials with a contract value of $1,987.23 and an ultimate completion date of June 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery supporting federal...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Gentamicin 800 mg/20 mL vials. This firm fixed-price delivery order, valued at $2,292.52, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by July 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. Gentamicin is a critical antibiotic used in military...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,286.51, is for the delivery of 4,568,577,972 vials of 800 mg/20 mL Gentamicin, a pharmaceutical product used for treating various bacterial infections. The contract has an ultimate completion date of June 18, 2025 and is not set aside for any specific business type....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gentamicin Pediatric 20 mg/2 ml vials, with a ceiling value of $2,863.71 and a performance period ending on June 10, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for GENTAMICIN 800 MG/20 ML VIAL 20ML, a pharmaceutical product, with a completion date of February 16, 2024 and a potential value of $3,436.19. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its...
- This is a $2,741.83 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 800 mg/20 ml vials of the antibiotic Gentamicin, with a performance period through May 12, 2023. This award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a...
- This is a $1,392.65 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4566811385 - GENTAMICIN 800 MG/20 ML VIAL 20ML, with a period of performance ending on December 31, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency awarded a delivery order valued at $11,614.30 to AmerisourceBergen Drug Corp for the supply of Ampicillin 2 GM Add-Vantage VLS on September 17, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- SPE2DB24D6044Indefinite Delivery Contract
- SPE2DB24D6044-SPE2DB25FLJJVDelivery Order
The Defense Logistics Agency awarded a $10,558.45 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Gentamicin pediatric 20 mg/2 mL vials. This firm fixed-price contract, with an ultimate completion date of August 22, 2025, represents a competitively awarded (non-set-aside) procurement through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement needs, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's existing $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. The antibiotic procurement exemplifies the company's role in fulfilling critical medical commodity needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 8/21/25 |